title: Pseudotumor cerebri in an infant after L-thyroxine therapy for transient neonatal hypothyroidism.
abstract: Pseudotumor cerebri is generally a benign disorder. It has been reported to occur in hypothyroidism, particularly after the initiation of L-thyroxine replacement therapy. Previous case reports have involved children primarily in the peripubertal age range (approximately 8 to 13 years). We report here the development of pseudotumor cerebri in an infant who required treatment with L-thyroxine for transient neonatal hypothyroidism as a result of maternal thyroid-stimulating hormone receptor-blocking antibodies.
authors.affiliation: Department of Pediatrics, Monteflore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA.
authors.forename: S
authors.initials: S
authors.lastname: Raghavan
authors.forename: J
authors.initials: J
authors.lastname: DiMartino-Nardi
authors.forename: P
authors.initials: P
authors.lastname: Saenger
authors.forename: B
authors.initials: B
authors.lastname: Linder
mesh_terms: D003409:Congenital Hypothyroidism; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy*; D007231:Infant, Newborn; D011559:Pseudotumor Cerebri / Q000139:chemically induced*; D013974:Thyroxine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D013974:Thyroxine